Ultrahuman Eyes New Markets and Products to De-Risk Revenue Streams

Ultrahuman eyes new markets and products to de-risk revenue streams

Ultrahuman is diversifying its revenue streams and expanding internationally after a US import ban on smart rings. The company is focusing on new products like blood tests and glucose monitoring, while aiming for India to contribute 25% of revenue by 2030.

Ultrahuman Secures INR 100 Cr Debt Amid US Ban

Smart ring manufacturer Ultrahuman has raised INR 100 Cr ($11.2 Mn)  in venture debt from Alteria Capital as it looks to scale its products and expand into more markets. The Bengaluru-based startup said the new capital will help it build more features, grow its software-led revenue, and strengthen its sports and research partnerships.  In a statement, Ultrahuman CEO Mohit Kumar shared the startup’s plans to maintain cost discipline while expandi…

Ultrahuman raises Rs 100 cr venture debt from Alteria Capital for market expansion

New Delhi, Nov 20 (PTI) Ultrahuman, the Bengaluru-based health technology firm, has raised Rs 100 crore in venture debt from Alteria Capital to support the next stage of its growth.The new financing enables Ultrahuman to deepen innovation and accelerate its market expansion, sports and research partnerships, and development of new features and software revenue streams, according to a release. "We've built Ultrahuman on the principles of cost-dis…